Current data in clinicopathological characteristics of primary hepatic tumors

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 3 SUPPL., 2012, Pages 719-724

  Turdean, S ^a   Gurzu, Simona ^b   Turcu, M ^b   Voidazan, S ^b   Sin, Anca ^c  

^a 'Dr Gheorghe Marinescu' Municipal Hospital   (Romania)

^b Department of Pathology ^*  (Romania)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cavernous hemangioma; Cholangiocarcinoma; Hepatocellular carcinoma; Primary liver tumors

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84870338960     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gomaa AI, Khan SA, Leen ELS, Waked I, Taylor-Robinson SD, Diagnosis of hepatocellular carcinoma, World J Gastroenterol, 2009, 15(11):1301-1314.
2. Schuppan D, Afdhal NH, Liver cirrhosis, Lancet, 2008, 371(9615):838-851.
3. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD, Hepatocellular carcinoma: epidemiology, risk factor and pathogenesis, World J Gastroenterol, 2008, 14(27):4300-4308.
4. Park J, Kim MH, Kim KP, Park do H, Moon SH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK, Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study, Gut Liver, 2009, 3(4):298-305.
5. Bosman FT, Carneiro F, Hruban RH, Theise ND, Tumours of the digestive system, WHO Classification of Tumours, IARC Press, Lyon, 2010, 217-225.
6. Boyle P, Atlas of cancer mortality in the European Union and the European Economic Area 1993-1997, IARC Scientific Publications, Lyon, 2008, 133-135.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10, IARC, Lyon, 2010, http://globocan.iarc.fr, accessed on 07/04/2012.
8. th edition, Springer, New York, 2010, 237-254.
9. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, Huo TI, Sheen IJ, Lee SD, Lui WY, Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma, J Hepatol, 2009, 51(5):890-897.
10. Cheng CH, Lee CF, Wu TH, Chan KM, Chou HS, Wu TJ, Yu MC, Chen TC, Lee WC, Chen MF, Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma, World J Surg Oncol, 2011, 9:114.
11. Ishikawa T, Clinical features of hepatitis B virus-related hepatocellular carcinoma, World J Gastroenterol, 2010, 16(20):2463-2467.
12. El-Serag HB, Rudolph KL, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastro-enterology, 2007, 132(7):2557-2576.
13. James WP, The epidemiology of obesity: the size of the problem, J Intern Med, 2008, 263(4):336-352.
14. Blonski W, Kotlyar DS, Forde KA, Non-viral causes of hepatocellular carcinoma, World J Gastroenterol, 2010, 16(29):3603-3615.
15. Yang J, Yan LN, Current status of intrahepatic cholangio-carcinoma, World J Gastroenterol, 2008, 14(41):6289-6297.
16. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L'Abbé KA, Wild CP, Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma, Int J Cancer, 1991, 48(3):323-328.
17. Ries LAG, Melbert D, Krapcho M, SEER Cancer Statistics Review, 1975-2005, Bethesda, MD, National Cancer Institute, 2008, http://seer.cancer.gov/csr/1975_2005.
18. Qu ZW, He Q, Lang R, Pan F, Jin ZK, Sheng QS, Zhang D, Zhang XS, Chen DZ, Giant hepatobiliary cystadenoma in a male with obvious convex papillate, World J Gastroenterol, 2009, 15(15):1906-1909.
19. Ren XL, Yan RL, Yu XH, Zheng Y, Liu JE, Hou XB, Zuo SY, Fu XY, Chang H, Lu JH, Biliary cystadenocarcinoma diagnosed with real-time contrast-enhanced ultrasono-graphy: report of a case with diagnostic features, World J Gastroenterol, 2010, 16(1):131-135.
20. Roebuck DJ, Perilongo G, Hepatoblastoma: an oncological review, Pediatr Radiol, 2006, 36(3):183-186.
21. Mani H, Van Thiel DH, Mesenchymal tumors of the liver, Clin Liver Dis, 2001, 5(1):219-257, viii.
22. Brancatelli G, Federle MP, Blachar A, Grazioli L, Hemangioma in the cirrhotic liver: diagnosis and natural history, Radiology, 2001, 219(1):69-74.
23. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H, Hepatic haemangiomas: possible association with female sex hormones, Gut, 2004, 53(9):1352-1355.
24. Barthelmes L, Tait IS, Liver cell adenoma and liver cell adenomatosis, HPB (Oxford), 2005, 7(3):186-196.
25. Barazani Y, Hiatt JR, Tong MJ, Busuttil RW, Chronic viral hepatitis and hepatocellular carcinoma, World J Surg, 2007, 31(6):1243-1248.
26. Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, Lam Chan S, Yeo W, Sung JJ, Mok TS, High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma, J Clin Oncol, 2008, 26(2):177-182.